Orelabrutinib

CAS : 1655504-04-3

Ref. 3D-FRC50404

Informations sur le produit

• Nom: Orelabrutinib

Description

Orelabrutinib is a potent inhibitor of Bruton's tyrosine kinase (BTK). It has been shown to inhibit the BTK enzyme in both human and mouse cells, which prevents activation of the B-cell receptor and inhibits immunoglobulin production. Orelabrutinib is also a 5-HT1A agonist and has been shown to have anti-cancer effects on drug-resistant acute lymphocytic leukemia. The drug binds to the active site of BTK as a covalent inhibitor, resulting in its inhibition. Orelabrutinib also acts as an antagonist at serotonin receptors 5-HT1A, leading to its potential therapeutic effects in autoimmune diseases.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 427.5 g/mol
• Formule: C₂₆H₂₅N₃O₃
• Degré de pureté: Min. 95%